Search

Search results
Logo Gebu
  • Search
Search results
  • Home
  • Years
  • Index
  • About Ge-Bu
  • Contact
  • Nederlands
Nederlands
Geneesmiddelen Bulletin
https://www.ge-bu.nl
  1. Home
  2. Years
  3. 2022
  4. Nr. 8

Year 2022 (56)

Edition nr. 8


New drug: rimegepant for migraine attacks

Erik P. Schwarz
Nr 8|2022 (56)|Page 65-68|New|doi: 10.35351/gebu.2022.8.15|29-08-2022

Two million people in the Netherlands regularly experience migraine. In addition to preventive medication, a large proportion of patients also use drugs for the acute treatment of a migraine attack. The cornerstone of this therapy are the triptan ...

In short Read article


Edition nr. 7 (2022) Edition nr. 9 (2022)
Choose year
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
Choose edition
  • Nr. 12
  • Nr. 11
  • Nr. 10
  • Nr. 9
  • Nr. 8
  • Nr. 7
  • Nr. 6
  • Nr. 5
  • Nr. 4
  • Nr. 3
  • Nr. 2
  • Nr. 1
  • Nederlands
Copyright © 2023 Ge-Bu. All rights reserved. 
Cookies | Disclaimer

Pill verdict

Pill verdict: sufficient
Pill verdict 'sufficient' means that this medicine has sufficient added value for use in the treatment of the condition.
Pill verdict: moderate
Pill verdict 'moderate' means that this medicine has moderate added value for use in the treatment of the condition, or that the added value of the medicine can't be assessed yet on the basis of the current research results.
Pill verdict: insufficient
Pill verdict 'insufficient' means that this medicine has insufficient added value for use in the treatment of the condition.